1. Home
  2. SELF vs XLO Comparison

SELF vs XLO Comparison

Compare SELF & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Self Storage Inc.

SELF

Global Self Storage Inc.

HOLD

Current Price

$5.22

Market Cap

58.0M

Sector

Real Estate

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$9.15

Market Cap

49.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SELF
XLO
Founded
1983
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.0M
49.8M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
SELF
XLO
Price
$5.22
$9.15
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$6.00
$28.00
AVG Volume (30 Days)
15.0K
33.3K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
5.25%
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$12,705,245.00
$43,766,000.00
Revenue This Year
$3.04
N/A
Revenue Next Year
$3.47
$168.77
P/E Ratio
$131.25
N/A
Revenue Growth
1.40
589.88
52 Week Low
$4.73
$0.46
52 Week High
$5.63
$9.89

Technical Indicators

Market Signals
Indicator
SELF
XLO
Relative Strength Index (RSI) 48.98 58.36
Support Level $4.96 $7.47
Resistance Level $5.27 N/A
Average True Range (ATR) 0.11 0.54
MACD 0.02 0.05
Stochastic Oscillator 53.57 59.42

Price Performance

Historical Comparison
SELF
XLO

About SELF Global Self Storage Inc.

Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: